US 10457670
Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease
granted A61KA61K31/045A61K31/13
Quick answer
US patent 10457670 (Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease) held by Takeda Pharmaceutical Company Limited expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/045, A61K31/13, A61K31/325, A61K31/4035